rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2011-3-1
|
pubmed:abstractText |
Induced pluripotent stem cells (iPSCs) have radically advanced the field of regenerative medicine by making possible the production of patient-specific pluripotent stem cells from adult individuals. By developing iPSCs to treat HIV, there is the potential for generating a continuous supply of therapeutic cells for transplantation into HIV-infected patients. In this study, we have used human hematopoietic stem cells (HSCs) to generate anti-HIV gene expressing iPSCs for HIV gene therapy. HSCs were dedifferentiated into continuously growing iPSC lines with four reprogramming factors and a combination anti-HIV lentiviral vector containing a CCR5 short hairpin RNA (shRNA) and a human/rhesus chimeric TRIM5? gene. Upon directed differentiation of the anti-HIV iPSCs toward the hematopoietic lineage, a robust quantity of colony-forming CD133(+) HSCs were obtained. These cells were further differentiated into functional end-stage macrophages which displayed a normal phenotypic profile. Upon viral challenge, the anti-HIV iPSC-derived macrophages exhibited strong protection from HIV-1 infection. Here, we demonstrate the ability of iPSCs to develop into HIV-1 resistant immune cells and highlight the potential use of iPSCs for HIV gene and cellular therapies.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AC133 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1525-0024
|
pubmed:author |
pubmed-author:AndersonJoseph SJS,
pubmed-author:BauerGerhardG,
pubmed-author:CaryWhitneyW,
pubmed-author:DylanTT,
pubmed-author:GruenlohWilliamW,
pubmed-author:JungYunjoonY,
pubmed-author:KalomoirisStefanosS,
pubmed-author:KambalAmalA,
pubmed-author:LindseyMattM,
pubmed-author:McGeeJeannineJ,
pubmed-author:MitchellGaelaG,
pubmed-author:NaceyCatherineC,
pubmed-author:NoltaJan AJA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
584-93
|
pubmed:meshHeading |
pubmed-meshheading:21119622-Adult,
pubmed-meshheading:21119622-Antigens, CD,
pubmed-meshheading:21119622-Antigens, CD34,
pubmed-meshheading:21119622-Cell Differentiation,
pubmed-meshheading:21119622-Cells, Cultured,
pubmed-meshheading:21119622-Glycoproteins,
pubmed-meshheading:21119622-HEK293 Cells,
pubmed-meshheading:21119622-HIV Infections,
pubmed-meshheading:21119622-HIV-1,
pubmed-meshheading:21119622-Hematopoietic Stem Cells,
pubmed-meshheading:21119622-Humans,
pubmed-meshheading:21119622-Induced Pluripotent Stem Cells,
pubmed-meshheading:21119622-Macrophages,
pubmed-meshheading:21119622-Peptides,
pubmed-meshheading:21119622-RNA, Small Interfering,
pubmed-meshheading:21119622-Receptors, CCR5
|
pubmed:year |
2011
|
pubmed:articleTitle |
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
|
pubmed:affiliation |
Stem Cell Program, Department of Internal Medicine, University of California, Davis, Sacramento, California 95817, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|